1.
Observed means and standard deviations for clinical outcome variables at baseline, post-treatment and one-year follow-up within each group, within-group effects and between-group e...
2.
3.
4.
Results of cost-effectiveness analyses.
Prices health care units and productivity losses.
Indirect medical costs (travel costs).
Total reported units of healthcare utilization and total reported days of absenteeism and presenteeism in the ACT-group and CBT-group at over assessments.
Mean and median incremental costs and effects of the 2,500 bootstraps.
CONSORT 2010 checklist of information to include when reporting a randomised trial.
Cost-effectiveness planes of the sensitivity analyses.
Flowchart of study participants.
Cost-effectiveness plane reflecting the probability that blended ACT is cost-effective compared to CBT in terms of treatment responders.